Peptide questions · Amycretin
How long does amycretin take to work?
Reviewed Evidence: ModeratePublished by PepVault
Amycretin’s onset is days–2 weeks, its peak effect comes at 36 weeks (longest trial so far), and its typical duration is ongoing, by the library’s timeline (backed by moderate evidence).
The timeline’s basis: Phase 1 and 1b/2a (Dahl 2025, Lancet; Gasiorek 2025, Lancet), phase 2 in type 2 diabetes (Mora 2026, Lancet, SubQ and oral), renal PK (Oldenburg 2026), Novo Nordisk report Feb-3-2026, AMAZE and AMBITION records on ClinicalTrials.gov. Investigational.
Amycretin week by week
The library places six of its research notes on amycretin on the days they cover, from day 1 to day 252 and on: 2 on randomized trials and 4 on clinical data.
Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.
| When | The note | Evidence |
|---|---|---|
| Days 1–28 (weeks 1–4) | A very low start | Randomized trial |
| Days 57–140 (weeks 9–20) | The lowest dose tested for weight | Clinical data |
| Days 85–252 (weeks 13–36) | With type 2 diabetes | Randomized trial |
| Days 113–196 (weeks 17–28) | Five milligrams | Clinical data |
| Days 169–252 (weeks 25–36) | Twenty milligrams | Clinical data |
| From day 253 on | A long-term medicine, not a course | Clinical data |

Model. Individual results vary.
The amycretin timeline’s milestones
The library’s timeline for amycretin marks 5 points from week 1 to week 36, backed by moderate evidence overall.
- Week 1: Commonly reported: appetite dropping in the first days on the low start dose
- Week 4: Its trials stepped the dose up every 4 weeks
- Week 20: Phase 1b/2a: about 9.7% average loss at 1.25 mg after 20 weeks
- Week 28: Phase 1b/2a: about 16% average loss at 5 mg after 28 weeks
- Week 36: Phase 1b/2a: about 22% (20 mg) and 24% (60 mg) average loss vs about 2% on placebo
The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.
Why amycretin takes that long
Amycretin’s half-life is about 3.7 days (88 hours), so one dose is about 96.9% cleared after 18 days.
On its schedule (Weekly) the doses overlap, and the level of amycretin keeps climbing for about 15–18 days before it levels off, so the first 15–18 days run below the level the later weeks hold.
The notes on amycretin follow the trials’ dose steps, 1.25mg, 5mg and 20mg, so the later weeks also describe higher steps than the first ones; these are steps from studies, not a schedule for a person.
Amycretin against other metabolic & GLP-1 compounds
The library holds an onset-and-peak timeline for 21 metabolic & GLP-1 compounds, amycretin among them; 15 of the others share its onset of days–2 weeks.
| Compound | Onset | Peak effect |
|---|---|---|
| Semaglutide | Days–2 weeks | 60–68 weeks |
| Tirzepatide | Days–2 weeks | 72+ weeks |
| Retatrutide | Days–2 weeks | 48+ weeks |
| Dulaglutide | Days–2 weeks | 24–52 weeks (glucose) |
| Exenatide | First dose (after-meal glucose) | 24–30 weeks (HbA1c) |
| Setmelanotide | 1–2 weeks (hunger) | 52 weeks (BMI) |
| Orforglipron | Days–2 weeks | 72 weeks (trial endpoint) |
| Survodutide | Days–2 weeks | 76 weeks (trial endpoint) |
| Mazdutide | Days–2 weeks | 48–60 weeks |
| Pemvidutide | Days–2 weeks | 48+ weeks |
| Cagrilintide | Days–2 weeks | 26–68 weeks (trial endpoints) |
| Pramlintide | First meal (fullness, after-meal glucose) | 16–52 weeks (weight, HbA1c) |
| CagriSema | Days–2 weeks | 68+ weeks |
| Eloralintide | Days–2 weeks | 48 weeks (phase 2 endpoint) |
| Petrelintide | Days–2 weeks | 42 weeks (phase 2, still falling) |
| Amycretin | Days–2 weeks | 36 weeks (longest trial so far) |
| VK2735 | Days–2 weeks | 78 weeks (phase 3 endpoint, not yet read out) |
| Enicepatide | Days–2 weeks | 48 weeks (phase 2 endpoint, no plateau) |
| Ecnoglutide | Days–2 weeks | 48 weeks (phase 3, no plateau) |
| Efinopegdutide | Weeks | 24–52 weeks (trial endpoints) |
| SLU-PP-332 | Unknown in people | Unknown in people |
Questions people ask
How long does amycretin take to work?
Amycretin’s onset is days–2 weeks, its peak effect comes at 36 weeks (longest trial so far), and its typical duration is ongoing, by the library’s timeline (backed by moderate evidence).
When does amycretin reach its peak effect?
By the library’s timeline, amycretin’s peak effect comes at 36 weeks (longest trial so far), backed by moderate evidence.
How long is amycretin usually run?
The library’s timeline gives amycretin’s typical duration as ongoing; its cycle note says: Used continuously, once weekly, in its trials: up to 36 weeks so far, with doses stepped up every 4 weeks.
What does the library say about the first days on amycretin?
Its first note on amycretin, for days 1–28 (weeks 1–4), is “A very low start”, resting on randomized trials.